10 Ways To Reinvent Your Xarelto Lawsuit

From EEYEM Pilot Wiki
Jump to: navigation, search

Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical companies, such as the makers of Xarelto, have a duty to make sure that their drugs are reasonably safe for use - and failure to complete so may be grounds for compensation. Our lawyers are working difficult to get these hurt by the drug the compensation they are entitled to.

Whilst bleeding is a common complication associated with anticoagulants, it has been alleged that Xarelto is more harmful than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This means that, within the occasion of an emergency, sufferers could be at danger for irreversible bleeding issues, including life-threatening internal and gastrointestinal hemorrhaging.

In case you or perhaps a loved 1 suffered a serious bleeding event after taking Xarelto, you might have legal recourse. For more information, get in touch with us today to have your case reviewed, cost-free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future medical bills, lost wages, discomfort and suffering and, in circumstances of death, funeral costs. Furthermore, they are searching for punitive damages, which are typically awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Getting Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs within the lawsuits allege significant and fatal injuries, http://www.wangboshi.cc/ such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

Visit this page for far more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.